Clinical outcomes of and risk factors for secondary infection in patients with severe COVID-19: a multicenter cohort study in South Korea
Yong Sub Na, Ae-Rin Baek, Moon Seong Baek, Won-Young Kim, Jin Hyoung Kim, Bo young Lee, Gil Myeong Seong, Song-I Lee
Korean J Intern Med. 2023;38(1):68-79. Published online 2022 Nov 24 DOI: https://doi.org/10.3904/kjim.2022.084
Citations to this article as recorded by 
Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness
Kuei-Pin Chung, Jia-Ying Su, Yi-Fu Wang, Bugi Ratno Budiarto, Yu-Chang Yeh, Jui-Chen Cheng, Li-Ta Keng, Yi-Jung Chen, Ya-Ting Lu, Yi-Hsiu Juan, Kiichi Nakahira, Sheng-Yuan Ruan, Jung-Yien Chien, Hou-Tai Chang, Jih-Shuin Jerng, Yen-Tsung Huang, Shih-Yu Che
Frontiers in Immunology.2024;[Epub] CrossRef
Co-infections and secondary infections amid COVID-19 outbreaks in Vietnam
Hong Tham Pham, Thi Ha Truong, Kim-Huong Truong-Nguyen, Bao Khanh Nguyen, Minh-Hoang Tran
BMC Infectious Diseases.2024;[Epub] CrossRef
A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3 Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study
Ahmet Sari, Osman Ekinci, Kemal Tolga Saraçoğlu, Recep Balık, Mesut Aslan, Yelda Balık, Ceren Önal, Murat Aslan, Semra Cevher, Aylin Parmaksız, Şule Vatansever, Münire Canan Çicek, Özge Sayın Ayan, Gaye Şensöz Çelik, Açelya Toprak, Mehmet Yılmaz, Emine Yu
Journal of Korean Medical Science.2023;[Epub] CrossRef